Loengard Anna U's Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed May 20, 2024
- Accession no.
- 0001801170-24-000116
- Filed
- May 20, 2024
- Trade date
- May 16-17, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $25.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Loengard Anna UCIK 0001952723 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | Class A Common Stock | PPurchaseAcquired | +10,000 | $0.93 | +$9,300 | 10,000 | Indirect | |
| May 16, 2024 | Class A Common Stock | PPurchaseAcquired | +15,600 | $0.96 | +$14,976 | 15,600 | Indirect | |
| May 16, 2024 | Class A Common Stock | PPurchaseAcquired | +1,485 | $0.94 | +$1,395.9 | 15,110 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.